The role of adrenodoxin in adrenal steroidogenesis

Current Opinion in Endocrinology and Diabetes

Volumn 7, Issue 3, 2000, Pages 109-115

  Bernhardt, Rita ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENODOXIN; CYTOCHROME P450; MITOCHONDRIAL ENZYME;

ADRENAL GLAND; AMINO ACID SEQUENCE; BIOSYNTHESIS; CATTLE; ELECTRON TRANSPORT; HUMAN; MITOCHONDRION; NONHUMAN; PROTEIN PROTEIN INTERACTION; REVIEW; STEROIDOGENESIS; TRANSCRIPTION REGULATION;

EID: 0034087490     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-200006000-00002     Document Type: Review

References (55)

1. 1 Miller WL, Tyrell JB: The adrenal cortex. In: Endocrinology and Metabolism. Edited by Felig P, Baxter J, Frohman L. New York: McGraw Hill, 1995:555-711.
2. 2 Miller WL: Mitochondrial specificity of the early steps in steroidogenesis. J Steroid Biochem Molec Biol 1995, 55:607-616.
3. 3 Bernhardt R: Cytochrome P450: Structure, function, and generation of reactive oxygen species. Rev Physiol Biochem Pharmacol 1995, 127:137-221.
4. 4 Usanov SA, Chashchin VL, Akhrem AA: Cytochrome P450-dependent pathways of the biosynthesis of steroid hormones. In: Frontiers in Biotransformation, Vol 3. Edited by Ruckpaul K, Rein H. Berlin: Akademie-Verlag, 1990:1-57.
5. 5 Sligar SG, Gunsalus IC: Proton coupling in the cytochrome P-450 spin and redox equilibria. Biochemistry 1979, 18:2290-2295.
6. 6 Miller WL: Why nobody has P450scc (20,22 Desmoslase) deficiency. J Clin Endocrinol Metab 1998, 83:1399-1400.
7. 7 Sparkes RS, Klisak I, Miller WL: Regional mapping of genes encoding human steroidogenic enzymes: P450scc to 15q23-q24, adrenodoxin to 11q22; adrenodoxin reductase to 17q24-q25; and P450c17 to 10q24-q25. DNA Cell Biol 1991, 10:359-365.
8. 8 Chua SC, Szabo P, Vitek A, et al.: Cloning of cDNA encoding steroid 11 beta-hydroxylase (P450c11). Proc Natl Acad Sci 1987, 7193-7197.
9. 9 Pascoe L, Curnow KM, Slutsker L, et al.: Glucocorticoid-suppressible hyperaldostonerism results from hybrid genes created by unequal corssovers between CYP11B1 and CYP11B2. Proc Natl Acad Sci 1992, 89:8327-8331.
10. 10 Nabi N, Omura T: In vitro synthesis of adrenodoxin and adrenodoxin reductase: existence of a putative large precursor form of adrenodoxin. Biochem Biophys Res Commun 1980, 97:680-686.
11. 11 Nabi N, Omura T: In vitro synthesis of NADPH-adrenodoxin reductase and adrenodoxin of bovine adrenal cortex, and the existense of a lare precursor of adrenodoxin. J Biochem 1983, 94:1529-1538.
12. 12 Nabi N, Ishikawa T, Ohashi M, Omura T: Contribution of cytoplasmic free and membrane-bound ribosomes to the synthesis of NADPH-adrenodoxin reductase and adrenodoxin of bovine adrenal cortex mitochondria. J Biochem 1983, 94:1505-1515.
13. 13 Matocha MF, Waterman MR: Synthesis and processing of mitochondrial steroid hydroxylases. In vivo maturation of the precursor forms of cytochrome P450scc, cytochrome P-450(11)beta, and adrenodoxin. J Biol Chem 1985, 260:12259-12265.
14. 14 Omura T: Mitochondria-targeting sequence, a multi-role sorting sequence recognized at all steps of protein import into mitochondria. J Biochem 1998, 123:1010-1016.
15. 15 Ichikawa Y, Ichikawa M, Ishigami S, et al.: Localization of cytochrome P450-linked mixed function oxidase and steroid hydroxylations within zones of bovine adrencortices. Biochim Biophys Acta 1978, 529:263-269.
16. 16 Mitani F, Ishimura Y, Izumi S, Watanabe K: Immunohistochemical localization of adrenodoxin and adrenodoxin reductase in bovine adrenal cortex. Acta Endocrinol 1979, 90:317-327.
17. 17 Hatano O, Sagara Y, Omura T, Takakusu A: Immunocytochemical localization of adrenodoxin in bovine adrenal cortex by protein A-gold technique. Histochemistry 1989, 91:89-97.
18. 18 Ishimura K, Fujita H: Light and electron microscopic immunohistochemistry of the localization of adrenal steroidogenic enzymes. Microscopy Res Techn 1997, 36:445-453.
19. 19 Müller A, Müller JJ, Muller YA, et al.: New aspects of electron transfer revealed by the crystal structure of a truncated bovine adrenodoxin, Adx (4108). Structure 1998, 6:269-280.
20. 20 Lambeth JD: Enzymology of mitochondrial side-chain cleavage by cytochrome P450scc. In: Frontiers in Biotransformation, Vol. 3. Edited by Ruckpaul K, Rein H. Berlin: Akademie-Verlag 1990:58-100.
21. 21 Schwarz D, Chernogolov A, Kisselev P: Complex formation in vesicle-reconstituted mitochondrial cytochrome P450 systems (CYP11A1 and CYP11B1) as evidenced by rotational diffusion experiments using EPR and ST-EPR. Biochemistry 1999, 38:9456-9464. Direct evidence for the formation of a complex between CYP11A1 and CYP11B1, but not between CYP11A1 and AdR was obtained using reconstituted liposomal systems and EPR and ST-EPR. These data confirm the shuttle mechanism of electron transfer to vesicle-reconstituted CYP11A1 and CYP11B1.
22. 22 Ziegler GA, Vonrhein C, Hanukoglu I, Schulz GE: The structure of adrenodoxin reductase of mitochondrial P450 systems: electron transfer for steroid biosynthesis. J Mol Biol 1999, 289:981-990. The crystal structure of native AdR was determined at 2.8 A resolution and that of the respective recombinant enzyme at 1.7 A resolution. The structure explains how the observed semiquinone is stabilised. It further shows that AdR has a highly asymmetric charge distribution, which most likely controls the approach of adrenodoxin, which previously has been shown to reveal an asymmetric charge distribution on its surface, too (see Müller [19]). A model of adrenodoxin/AdR interaction has been suggested, in which adrenodoxin binds to a positively charged cleft of the AdR.
23. 23 Vickery LE: Molecular recognition and electron transfer in mitochondrial steroid hydroxylase systems. Steroids 1997, 62:124-127.
24. 24 Pikuleva IA, Cao C, Waterman MR: An additional electrostatic interaction between adrenodoxin and P450c27 (CYP27A1) results in tighter binding than between adrenodoxin and P450scc (CPY11A1). J Biol Chem 1999, 274:2045-2052. CYP27A1 was found to have significantly higher affinity to adrenodoxin than CYP11A1. Formation of an additional electrostatic interaction via Arg-418, in addition to participation of the conserved residues Lys-354 and Lys-358 in electrostatic contacts to adrenodoxin, has been identified as the reason for this observation. This indicates changes in adrenodoxin binding to different P450s.
25. 25 Pikuleva IA, Tesh K, Waterman MR, Kim Y: The tertiary structure of full-length bovine adrenodoxin suggest functional dimers. Arch Biochem Biophys 2000, 373:44-55.
26. 26 Yamazaki T, McNamara BC, Jefcoate CR: Competition for electron transfer between cytochromes P450scc and P45011 beta in rat adrenal mitochondria. Mol Cell Endocrinol 1993, 95:1-11.
27. 27 Cao P, Bernhardt R: Interaction of CYP11B1 (cytochrome P45011β) with CYP11A1 (cytochrome P-450scc) in COS-1 cells. Eur J Biochem 1999, 262:720-726.
28. 28 Ikushiro S, Kominami S, Takemori S: Adrenal P-450scc modulates activity of P45011 beta in liposomal and mitochondrial membranes: implication of P-450scc in zone specificity of aldosterone biosynthesis in bovine adrenal. J Biol Chem 1992, 267:1464-1469.
29. 29 Kominami S, Harada D, Takemori S: Regulation mechanism of the catalytic activity of bovine adrenal cytochrome P-450(11)beta. Biochim Biophys Acta 1994, 1192:234-240.
30. 30 Sugano S, Miura R, Morishima N: Identification of intermediates in the conversion of cholesterol to pregnenolone with a reconstituted cytochrome p-450scc system: accumulation ot the intermediate modulated by the adrenodoxin level. J Biochem (Tokyo) 1996, 120:780-787.
31. 31 Zuber MX, Mason JI, Simpson ER, Waterman MR: Simultaneous transfection of COS-1 cells with mitochondrial and microsomal steroid hydroxylases: incorporation of a steroidogenic pathway into nonsteroidogenic cells. Proc Natl Acad Sci 1988, 85:699-703.
32. 32 Tuckey RC, Woods ST, Tajbakhsh, M: Electron transfer to cytochrome P-450scc limits cholesterol-side-chain-cleavage activity in the human placenta. Eur J Biochem 1997, 244:835-839.
33. 33 Ohnishi T, Wada A, Nonaka Y, et al.: Effect of phospholipid on aldosterone biosynthesis by a cytochrome P-450 (11) beta-reconstituted system. Biochem Int 1984, 9:715-732.
34. 34 Seybert DW: Lipid regulation of bovine cytochrome P45011beta activity. Arch Biochem Biophys 1990, 279:188-194.
35. 35 Schwarz D, Kisselev P, Pfeil W, et al.: Evidence that nonbilayer phase propensity of the membrane is important for the side chain cleavage activity of cytochrome P450SCC (CYP11A1). Biochemistry 1997, 36:14262-14270.
36. 36 Kisselev P, Tuckey RC, Woods ST, et al.: Enzymatic properties of vesicle-reconstituted human cytochrome P450SCC (CYP11A1): differences in functioning of the mitochondrial electron-transfer chain using human and bovine adrenodoxin and activation by cardiolipin. Eur J Biochem 1999, 260:768-773.
37. 37 Imai T, Yamazaki, T, Kominami S: Kinetic studies on bovine cytochrome P45011β catalyzing successive reactions from deoxycorticosterone to aldosterone. Biochemistry 1998, 37:8097-8104.
38. 38 Uhlmann H, Kraft R, Bernhardt R: Mutations of tyrosine 82 in bovine adrenodoxin that affect binding to cytochrome P45011A1 and P45011B1, but not electron transfer. J Biol Chem 1994, 269:22557-22564.
39. 39 Cao P, Bernhardt R: Modulation of aldosterone biosynthesis by adrenodoxin mutants with different electron transfer efficiencies. Eur J Biochem 1999, 265:152-159. It was demonstrated that truncated adrenodoxin mutants, possessing enhanced electron transfer abilities, produce increases in corticosterone and aldosterone biosynthesis when incubated with liposomal bovine CYP11B1. The effect of truncated adrenodoxin mutants on the product pattern of bovine CYP11B1 was confirmed in COS-1 cells. Moreover, it was demonstrated that in COS-1 cells the truncated mutants also enhance aldosterone formation relative to the formation of corticosterone by human CYP11B2. This implies that conditions changing the electron transfer abilities of adrenodoxin could have an impact on aldosterone formation, thus indicating a new regulatory level of aldosterone biosynthesis.
40. 40 Peters J, Hampf M, Peters B, Bernhardt R: Molekularbiologie, Klinik und Therapie steroidbedingter Hypertonien. In: Herz-Kreislauf-Erkrankungen. Edited by Ganten D, Ruckpaul K. Berlin: Springer-Verlag, 1998:413-452.
41. 41 Malee MP, Wu Ke-Ying: Adrenocortical activity in the newborn spontaneously hypertensive rat. AJH 1999, 12:511-518.
42. 42 Kramer RE, Anderson CM, Peterson JA, Simpson ER, Waterman MR: Adrenodoxin biosynthesis by bovine adrenal cells in monolayer culture. Induction by adrenocorticotropin. J Biol Chem 1982, 257:14921-14925.
43. 43 Hanukoglu I, Feuchtwanger R, Hanukoglu A: Mechanism of corticotropin and cAMP induction of mitochondrial cytochrome P450 system enzymes in adrenal cortex cells. J Biol Chem 1990, 256:20602-20608.
44. 44 Tremblay A, LeHoux JG: Influence of captopril on adrenal cytochrome P450s and adrenodoxin expression in high potassium or low sodium intake. J Steroid Biochem Mol Biol 1992, 41:799-808.
45. 45 Tremblay A, LeHoux JG: Transcriptional activation of adrenocortical steroidogenic genes by high potassium or low sodium intake. FEBS Lett 1993, 17:211-215.
46. 46 Ohnishi T, Wada A, Nonaka Y, et al.: Effect of calmodulin on aldosterone synthesis by a cytochrome P-45011 beta-reconstituted system from bovine adrenocortical mitochondria. J Biochem (Tokyo) 1986, 100:1065-1076.
47. 47 Kruse M, Bornstein SR, Uhlmann K, et al.: Leptin down-regulates the steroid producing system in the adrenal. Endocrin Res 1998, 24:587-590.
48. 48 Lado-Abeal J, Mrotek JJ, Stocco DM, Norman RL: Effect of leptin on ACTH-stimulated secretion of cortisol in rhesus macaques and on human adrenal carcinoma cells. Eur J Endocrinol 1999, 141:534-538.
49. 49 Barkan D, Jia H, Dantes A, et al.: Leptin modulates the glucocoticoid-induced ovarian steroidogenesis. Endocrinology 1999, 140:1731-1738. Leptin (0.6-18 nM) suppressed ovarian steroid synthesis costimulated by follicle-stimulating hormone and dexamethasone. Production of pregenenolone, progesterone, and 20α-hydroxy-4-pregnen-3-one was inhibited by leptin. The inhibition was due at least in part to reduced expression of adrenodoxin. This data indicates that changing the amount of adrenodoxin exerts a regulatory effect on adrenodoxin-dependent steroid biosynthesis.
50. 50 Addya S, Anandatheerthavarada HK, Biswas G, et al.: Targeting of NH-terminal-processed microsomal protein to mitochondria: a novel pathway for the biogenesis of hepatic mitochondrial P450MT2. J Cell Biol 1997, 139:589-599.
51. 51 Anandatheerthavarada HK, Biswas G, Mullick J, et al.: Dual targeting of cytochrome P4502B1 to endoplasmic reticulum and mitochondria involves a novel signal activitation by cyclic AMP-dependent phosphorylation at Ser128. EMBO J 1999, 18:5494-5504. It was demonstrated that CYP2B1 contains a chimeric mitochondrial and endoplasmic reticulum targeting signal at its N-terminus. Inducers of cyclic adenosine monophosphate and protein kinase A-mediated phosphorylation of CYP2B1 at Ser128 activate the signal for mitochondrial targeting and this way modulate its mitochondrial or endoplasmic reticulum destination. This observation demonstrates a novel regulatory mechanism by which cyclic adenosine monophosphate modulates the targeting of a protein to two distinct organelles.
52. 52 Neve EP, Ingelmann-Sundberg M: A soluble NH(2)-terminally truncated catalytically active form of rat cytochrome P450 2E1 targeted to liver mitochondria(1). FEBS Lett 1999, 460:309-314.
53. 53 Anandatheerthavarada HK, Addya S, Mullick J, Avadhani NG: Interaction of adrenodoxin with P4501A1 and its truncated form P450MT2 through different domains: differential modulation of enzyme activities. Biochemistry 1998, 37:1150-1160.
54. 54 Bhagwat SV, Biswas G, Anandatheerthavarada HK, et al.: Dual targeting property of the N-terminal signal sequence of P4501A1: targeting of heterologous proteins to endoplasmic reticulum and mitochondria. J Biol Chem 1999, 274:24014-24022.
55. 55 Monnier N, Defaye G, Chambaz EM: Phosphorylation of bovine adrenodoxin: structural study and enzymatic activity. Eur J Biochem 1987, 169:147-153.